-
Opsumit awaiting approval as treatment for inoperable CTEPH
Actelion Pharmaceuticals submitted a supplemental new drug application to the FDA seeking expanded approval for Opsumit (macitentan) as treatment for inoperable CTEPH.
Read more about it here: “Actelion Seeks Expanded Approval for Opsumit as Treatment for Inoperable CTEPH”
Do you require treatment for CTEPH? How have you managed it so far?
Sorry, there were no replies found.
Log in to reply.